Testing effectiveness (Phase 2)Looking for participantsNCT07174583
What this trial is testing
IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Who this might be right for
Small-cell Lung CancerNeuroendocrine CarcinomasSolid Tumor Show to Express DLL3
IDEAYA Biosciences 208